이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Bio-Techne 관리
관리 기준 확인 2/4
Bio-Techne's CEO는 Kim Kelderman, Feb2024 에 임명되었습니다 의 임기는 1년 미만입니다. 총 연간 보상은 $ 2.61M, 22.6% 로 구성됩니다. 22.6% 급여 및 77.4% 보너스(회사 주식 및 옵션 포함). 는 $ 2.89M 가치에 해당하는 회사 주식의 0.025% 직접 소유합니다. 2.89M. 경영진과 이사회의 평균 재임 기간은 각각 2.1 년과 7.6 년입니다.
주요 정보
Kim Kelderman
최고 경영자
US$6.9m
총 보상
| CEO 급여 비율 | 11.1% |
| CEO 임기 | less than a year |
| CEO 소유권 | 0.03% |
| 경영진 평균 재임 기간 | 1.1yrs |
| 이사회 평균 재임 기간 | 7.7yrs |
최근 관리 업데이트
Recent updates
Is Bio-Techne (NASDAQ:TECH) A Risky Investment?
Sep 26
Why Bio-Techne Corporation (NASDAQ:TECH) Could Be Worth Watching
Sep 11Bio-Techne Corporation's (NASDAQ:TECH) Price In Tune With Earnings
Aug 24When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Jun 09Bio-Techne Corporation's (NASDAQ:TECH) Shares Climb 33% But Its Business Is Yet to Catch Up
May 21These 4 Measures Indicate That Bio-Techne (NASDAQ:TECH) Is Using Debt Reasonably Well
Apr 30Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 32% Above Their Intrinsic Value Estimate
Apr 15Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Apr 04We Think Bio-Techne (NASDAQ:TECH) Can Stay On Top Of Its Debt
Jan 17Bio-Techne Corporation (NASDAQ:TECH) Investors Are Less Pessimistic Than Expected
Dec 30Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Dec 05Is Now An Opportune Moment To Examine Bio-Techne Corporation (NASDAQ:TECH)?
Oct 10Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Sep 22A Look At The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Sep 01At US$80.80, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Jul 10Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Jun 22With EPS Growth And More, Bio-Techne (NASDAQ:TECH) Makes An Interesting Case
Jun 07Bio-Techne Corporation's (NASDAQ:TECH) Intrinsic Value Is Potentially 25% Below Its Share Price
May 23When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Apr 05Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Mar 21Here's Why We Think Bio-Techne (NASDAQ:TECH) Is Well Worth Watching
Mar 06When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Jan 03We Think Bio-Techne (NASDAQ:TECH) Can Manage Its Debt With Ease
Dec 15Should You Be Adding Bio-Techne (NASDAQ:TECH) To Your Watchlist Today?
Nov 30Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Nov 17Bio-Techne releases new AVV viral titer assays
Oct 11At US$291, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Sep 26Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Sep 12Bio-Techne to seek shareholder approval for 4- for-1 stock split
Sep 01Is Now The Time To Put Bio-Techne (NASDAQ:TECH) On Your Watchlist?
Aug 29Bio-Techne releases Quantist Luminex data analysis software
Aug 18Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Aug 16CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | US$7m | US$760k | US$168m |
| Mar 31 2024 | n/a | n/a | US$203m |
| Dec 31 2023 | n/a | n/a | US$224m |
| Sep 30 2023 | n/a | n/a | US$247m |
| Jun 30 2023 | US$3m | US$590k | US$285m |
| Mar 31 2023 | n/a | n/a | US$271m |
| Dec 31 2022 | n/a | n/a | US$262m |
| Sep 30 2022 | n/a | n/a | US$292m |
| Jun 30 2022 | US$3m | US$562k | US$272m |
| Mar 31 2022 | n/a | n/a | US$225m |
| Dec 31 2021 | n/a | n/a | US$210m |
| Sep 30 2021 | n/a | n/a | US$177m |
| Jun 30 2021 | US$4m | US$530k | US$140m |
| Mar 31 2021 | n/a | n/a | US$184m |
| Dec 31 2020 | n/a | n/a | US$175m |
| Sep 30 2020 | n/a | n/a | US$248m |
| Jun 30 2020 | US$2m | US$500k | US$229m |
| Mar 31 2020 | n/a | n/a | US$187m |
| Dec 31 2019 | n/a | n/a | US$195m |
| Sep 30 2019 | n/a | n/a | US$93m |
| Jun 30 2019 | US$2m | US$452k | US$96m |
| Mar 31 2019 | n/a | n/a | US$121m |
| Dec 31 2018 | n/a | n/a | US$96m |
| Sep 30 2018 | n/a | n/a | US$128m |
| Jun 30 2018 | US$2m | US$73k | US$126m |
보상 대 시장: Kim 의 총 보상 ($USD 2.61M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 13.17M ).
보상과 수익: Kim 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.
CEO
Kim Kelderman (57 yo)
less than a year
테뉴어
US$6,852,495
보상
Mr. Kim Kelderman serves as Director of SLMP, LLC since November 2021. He serves as President of the Diagnostics and Genomics Segment at Bio-Techne. He served as Chief operating Officer at Bio-Techne Corpo...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Director | less than a year | US$6.85m | 0.025% $ 3.1m | |
| Executive VP of Finance & CFO | 10.4yrs | US$5.20m | 0.063% $ 7.9m | |
| Senior VP | 1.5yrs | US$1.46m | 0.0011% $ 132.4k | |
| President of Protein Sciences Segment | 2.7yrs | US$3.65m | 0.0028% $ 349.7k | |
| President of Diagnostics & Genomics | less than a year | US$2.27m | 데이터 없음 | |
| VP & CTO | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Director of Investor Relations & Corporate Development | no data | 데이터 없음 | 데이터 없음 | |
| Vice President of Sales and Marketing | no data | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Strategy & Corporate Development | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior VP & Chief Human Resources Officer | no data | 데이터 없음 | 데이터 없음 | |
| Managing Director | 8.2yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Analytical Solutions Division | 1.7yrs | 데이터 없음 | 데이터 없음 |
1.1yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 관리: TECH 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Director | 1.7yrs | US$6.85m | 0.025% $ 3.1m | |
| Independent Chairman of the Board | 21.7yrs | US$410.46k | 0.027% $ 3.4m | |
| Independent Director | 15.3yrs | US$300.46k | 0.029% $ 3.7m | |
| Independent Director | 7.7yrs | US$275.46k | 0.0078% $ 969.2k | |
| Independent Director | 34.7yrs | US$276.92k | 0.015% $ 1.9m | |
| Independent Director | 14.3yrs | US$290.46k | 0.027% $ 3.4m | |
| Independent Director | 4.2yrs | US$291.50k | 0.0036% $ 447.1k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 5.3yrs | US$275.46k | 0.0050% $ 620.8k | |
| Independent Director | 7.7yrs | US$275.46k | 0.0078% $ 969.2k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
7.7yrs
평균 재임 기간
63yo
평균 연령
경험이 풍부한 이사회: TECH 의 이사회는 경험(평균 재직 기간 7.6 년)으로 간주됩니다.